Identification of directly infected cells in the bone marrow of neonatal moloney murine leukemia virus-infected mice by use of a moloney murine leukemia virus-based vector.
Early bone marrow infection of Moloney murine leukemia virus (M-MuLV)-infected mice was studied. Previous experiments indicated that early bone marrow infection is essential for the efficient development of T lymphoma. In order to identify the cellular pathway of infection in the bone marrow, infection of mice with a helper-free replication-defective M-MuLV-based retroviral vector was carried out. Such a vector will undergo only one round of infection, without spreading to other cells; thus, cells infected by the initially injected virus (directly infected cells) can be identified. For these experiments, the BAG vector that expresses bacterial beta-galactosidase was employed. Neonatal NIH/Swiss mice were inoculated intraperitoneally with ca. 10(6) infectious units of a BAG vector pseudotyped with M-MuLV proteins, and bone marrow cells were recovered 2 to 12 days postinfection. Single-cell suspensions were tested for infection by staining with X-Gal (5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside) or by immunofluorescence with an anti-beta-galactosidase antibody. Two sizes of infected cells were evident: large multinucleated cells and small nondescript (presumptively hematopoietic) cells. Secondary stains for lineage-specific markers indicated that the large cells were osteoclasts. Some of the small cells expressed nonspecific esterase, which placed them in the myeloid lineage, but they lacked markers for hematopoietic progenitors (mac-1, gr-1, sca-1, and CD34). These results provide evidence for primary M-MuLV infection of osteoclasts or osteoclast progenitors in the bone marrow, and they suggest that known hematopoietic progenitors are not primary targets for infection. However, the subsequent spread of infection to hematopoietic progenitors was indicated, since bone marrow from mice infected in parallel with replication-competent wild-type M-MuLV showed detectable infection in small cells positive for mac-1 or CD34, as well as in osteoclasts.
Okimoto
M A
MA
Department of Molecular Biology and Biochemistry and Cancer Research Institute, University of California, Irvine, California 92697-3900, USA.
Fan
H
H
D016475:3T3 Cells; D000110:Acetylcholinesterase / Q000032:analysis; D000135:Acid Phosphatase / Q000032:analysis; D000818:Animals; D000831:Animals, Newborn; D018952:Antigens, CD34 / Q000032:analysis; D000943:Antigens, Differentiation / Q000032:analysis; D000950:Antigens, Ly / Q000032:analysis; D014408:Biomarkers, Tumor / Q000032:analysis; D001854:Bone Marrow Cells / Q000737:chemistry / Q000821:virology*; D037502:Galectin 3; D005822:Genetic Vectors / Q000502:physiology*; D006412:Hematopoietic Stem Cells / Q000276:immunology; D007527:Isoenzymes / Q000032:analysis; D007942:Leukemia, Experimental / Q000097:blood / Q000821:virology*; D016177:Macrophage-1 Antigen / Q000032:analysis; D008264:Macrophages / Q000276:immunology; D008533:Megakaryocytes / Q000201:enzymology; D008565:Membrane Proteins / Q000032:analysis; D051379:Mice; D008979:Moloney murine leukemia virus / Q000502:physiology*; D010010:Osteoclasts / Q000201:enzymology / Q000821:virology*; D012192:Retroviridae Infections / Q000097:blood / Q000821:virology*; D000071681:Tartrate-Resistant Acid Phosphatase; D014412:Tumor Virus Infections / Q000097:blood / Q000821:virology*
D018952:Antigens, CD34; D000943:Antigens, Differentiation; D000950:Antigens, Ly; D014408:Biomarkers, Tumor; D037502:Galectin 3; D007527:Isoenzymes; C074650:Ly6a protein, mouse; D016177:Macrophage-1 Antigen; D008565:Membrane Proteins; D000110:Acetylcholinesterase; D000135:Acid Phosphatase; D000071681:Tartrate-Resistant Acid Phosphatase